Navigation Links
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Date:10/30/2010

esentation, data from an ongoing Phase II combination study show that ANA598 added to pegylated interferon and ribavirin (current standard of care, or SOC) accelerated the rate of patients achieving undetectable levels of virus compared to placebo plus SOC, and that the antiviral response was equivalent at 200 mg bid and 400 mg bid ANA598.  The data from the study further show a durable antiviral response through 12 weeks, with only a single patient (<2% of patients in the ANA598 arms) experiencing viral breakthrough while receiving ANA598 plus SOC.  The safety profile of ANA598 through 12 weeks was excellent in the study, with reported adverse events being typical for patients treated with interferon and ribavirin alone, and the incidence of rash in patients receiving ANA598 200 mg bid plus SOC in the study was comparable to the group receiving placebo plus SOC.  

Additional data from the Phase II combination study will be presented reflecting the persistence of ANA598's benefit beyond week 12. 39 of 41 patients (>95%) who achieved undetectable levels of virus at week 12 in the two active arms have maintained undetectable levels while continuing to receive SOC through the latest available measurements.  For patients who, per protocol, concluded all treatment at week 24, interim analysis of SVR data for available patients indicates that 8 of 11 patients maintained undetectable levels of virus 12 weeks later, referred to as a Sustained Virological Response 12, or SVR12. The three patients who relapsed after concluding treatment at week 24 demonstrated the lowest week 4 ribavirin levels of all patients who concluded treatment at week 24, consistent with the known impact of ribavirin levels on converting on-treatment response to SVR.  Data is available for three patients 24 weeks after concluding treatment.  All three patients achieved an SVR24, recognized as a viral cure.

In the poster presentation on Tuesday, November
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... ALBANY, New York , August 27, 2014 /PRNewswire/ ... on United States  Laparoscopes Market Outlook ... to 2020", provides key market data on the ... in millions of US dollars, volume (in units) and ... Laparoscopes (Rigid Tip Video Laparoscopes and Flexible Tip Video ...
(Date:8/27/2014)... -- Reportlinker.com announces that a new market research report ... Eastern Europe 2014 http://www.reportlinker.com/p02312454/Baby-Food-Eastern-Europe-2014.html ... a new report by ERC that analyzes the Baby ... , key segments, features & developments, future projections ... which are currently affecting the industry. Furthermore, it profiles ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
Breaking Medicine Technology:United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
... Dendreon Corporation (Nasdaq: DNDN ) today announced ... Healthcare Conference in San Francisco on January 10, 2011 at ... audio webcast live and available for replay from Dendreon,s website, ... the live webcast, it will be archived on the site ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: ... president and chief executive officer, is scheduled to present at ... at 7:30 a.m. Pacific time. This presentation will ... audio webcast. To access the live and subsequently archived webcast ...
Cached Medicine Technology:
(Date:8/28/2014)... Now in its 4th year, Step for Hope ... brain aneurysm survivors. The ongoing mission of Step for Hope ... increase early detection and to help support individuals and families ... that you will be able to join this remarkable event ... for Hope Run/ Walk on Saturday, September 6, 2014. ...
(Date:8/28/2014)... Coveros, Inc., the market leader ... has partnered with InfoZen on the contract that ... of 2/4/2014 with U.S. Citizenship and Immigration Services ... that oversees lawful immigration to the United States. ... automate the integration and delivery of critical immigration ...
(Date:8/28/2014)... Aurora, Colo. (PRWEB) August 28, 2014 ... introduces a fun-loving man from Tallahassee, Fla. He’s a ... Broadway, but his 448-pound frame has made achieving that ... weight loss transformations, “Extreme Weight Loss” airs Tuesday, September ... , 49-year-old Rod always wears a big smile on ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 According to ... "Surgical Navigation Systems Market (Neurosurgical Navigation Systems, ENT Navigation ... Size, Share, Growth, Trends and Forecast 2014 - 2020", ... USD 218.5 million in 2013 and is expected to ... 2020, to reach an estimated value of USD 295.5 ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 The National ... Pierce Dennis, DrPH, MN, RN, FAAN, became the inaugural ... for the Advancement of the Science of Nursing Education ... seven that comprise the NLN Home for Transformative Excellence, ... capital a year ago. , Under Dr. Dennis’s ...
Breaking Medicine News(10 mins):Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2Health News:“Extreme Weight Loss”: Rod’s Journey Begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Health News:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4
... assistant professor of psychology in the School of Science ... Center for Aging Research affiliated scientist, has received a ... whether treatment of depression before one experiences a heart ... The research study, Beating the Blues for ...
... way to immobilise radioactive forms of iodine using a microwave, ... Sheffield. Iodine radioisotopes are produced by fission of uranium ... concern because it is highly mobile in the environment and ... cancer risk following long term exposure. Furthermore, iodine-129, which is ...
... HealthDay Reporter , MONDAY, May 23 (HealthDay News) -- Cutting ... pain and foregoing annual ECG screenings for healthy, low-risk patients ... experts say. Perhaps taking a page from David Letterman,s ... up with a "Top 5" list of action items for ...
... concern about the effects of media violence on children, ... and marketed to them. An Indiana University research study ... of such programs and their characters. In a ... , Andrew J. Weaver, an assistant professor of telecommunications ...
... that quality of life means more than just material ... to be interested in letting people,s subjective well-being guide ... in Ethiopia, a city of three million people, shows ... citizens themselves consider to make them satisfied with life. ...
... MONDAY, May 23 (HealthDay News) -- Women who gained 18 or ... three times more likely to develop gestational diabetes during their second ... the study, published in the May 23 online issue of ... to shed six or more pounds between babies cut their risk ...
Cached Medicine News:Health News:IUPUI study first to look at early treatment of depression to reduce heart disease risk 2Health News:Expert discovers simple method of dealing with harmful radioactive iodine 2Health News:Experts Issue 'Top 5' List for Better Primary Care 2Health News:Experts Issue 'Top 5' List for Better Primary Care 3Health News:New study finds that violence doesn't add to children's enjoyment of TV shows, movies 2Health News:New study finds that violence doesn't add to children's enjoyment of TV shows, movies 3Health News:What do policymakers know about the factors influencing people's well-being? 2Health News:Losing Baby Weight Cuts Odds of Pregnancy-Linked Diabetes 2
The Columbus microplate strip washer is for individual strips or whole plates.Programming and control are via an alphanumeric display. Up to 30 methods are stored for easy recall....
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
... Embla microplate washers available ... and most cell-based assays. Embla ... probes that have been optimized ... systems are robotic compatible and ...
ELISA Microplate Washer, Manual...
Medicine Products: